NE Field Diagnostics

NE Field Diagnostics develops and commercializes an innovative technology for lung function testing and monitoring. After extensive research and consulting with leading experts in the field of pulmonology, the company came to a conclusion; The best way to accurately measure lung functions is to find a way to measure alveolar pressure. The company succeeded calculating Airway-Resistance and respiratory-compliance, two of the most important parameters when diagnosing pulmonary diseases and also in monitoring chronic respiratory symptoms. The company aims to provide a reliable solution for home monitoring of chronic respiratory diseases, such as COPD and Asthma. It intends to prevent exacerbation and unnecessary hospitalization by providing a simple test that did not exist until now.

NE Field Diagnostics has raised $800K in total funding across 1 rounds. The company is currently at the Pre-Seed stage. Key investors include Undisclosed Investor(s), Israel Innovation Authority.

NE Field Diagnostics was founded in 2015 by Ofer Rahamim (Co-Founder & CEO), Dr. David Shoseyov (CMO).

NE Field Diagnostics operates in Health Tech & Life Sciences, Medical Devices, Medical Monitors, Diagnostics Devices, with core technologies in Sensing. Target customers: Healthcare & Life Sciences, Healthcare, Providers, Consumers, Demographics & Family, Children.

NE Field Diagnostics is based in Eyal, Israel, Center District.